[
  {
    "ts": null,
    "headline": "Jim Cramer is Recommending This Dividend Stock With 5% Yield for ‘Good Protection’",
    "summary": "We recently published a list of 10 Stocks to Watch as Trade Wars Begin. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks to watch as trade wars begin. Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC […]",
    "url": "https://finnhub.io/api/news?id=4fdc83ac9f6a3585c877107c0c2813dbb125577cb2fec27198570445a5a5bac2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745874244,
      "headline": "Jim Cramer is Recommending This Dividend Stock With 5% Yield for ‘Good Protection’",
      "id": 134131311,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of 10 Stocks to Watch as Trade Wars Begin. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks to watch as trade wars begin. Bill Strazzullo, Bell Curve Trading chief market strategist, said in a latest program on CNBC […]",
      "url": "https://finnhub.io/api/news?id=4fdc83ac9f6a3585c877107c0c2813dbb125577cb2fec27198570445a5a5bac2"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=04be5326c2155e95095d3f34fa37e2851fd3a60c8149162a40d143a1002e2927",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745858220,
      "headline": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "id": 134150127,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=04be5326c2155e95095d3f34fa37e2851fd3a60c8149162a40d143a1002e2927"
    }
  },
  {
    "ts": null,
    "headline": "BMSCH announces Children’s Same Day Services centre in the US",
    "summary": "The facility is designed to offer private care for children requiring regular, non-oncologic infusion therapies.",
    "url": "https://finnhub.io/api/news?id=0a6aca34abfae5d56f4c39110599231041bb370b9c30cc83b3fc8021a0f3acbc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745852187,
      "headline": "BMSCH announces Children’s Same Day Services centre in the US",
      "id": 134115369,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The facility is designed to offer private care for children requiring regular, non-oncologic infusion therapies.",
      "url": "https://finnhub.io/api/news?id=0a6aca34abfae5d56f4c39110599231041bb370b9c30cc83b3fc8021a0f3acbc"
    }
  },
  {
    "ts": null,
    "headline": "BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?",
    "summary": "Bristol Myers' first-quarter performance and raised annual guidance are encouraging. However, we recommend investors to stay on the sidelines as generic competition for legacy drugs and recent pipeline setbacks weigh on the stock.",
    "url": "https://finnhub.io/api/news?id=3b60622bb8b24278e416c56371d045be58b78cd807ca7dccf51a28ffc678518a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745846280,
      "headline": "BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?",
      "id": 134115370,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol Myers' first-quarter performance and raised annual guidance are encouraging. However, we recommend investors to stay on the sidelines as generic competition for legacy drugs and recent pipeline setbacks weigh on the stock.",
      "url": "https://finnhub.io/api/news?id=3b60622bb8b24278e416c56371d045be58b78cd807ca7dccf51a28ffc678518a"
    }
  },
  {
    "ts": null,
    "headline": "Retirement Strategy: 2 Blue Chip Dividends Now Way Too Cheap",
    "summary": "Verizonâs 5G growth and Bristol Myers Squibbâs innovation both provide strong income and growth prospects. Read more on BMY and VZ stocks here.",
    "url": "https://finnhub.io/api/news?id=8cb1e0015ec3a9a8b6510f0e1cdc81716bfea4a25991c7feab7e8c1c59938fa5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745824500,
      "headline": "Retirement Strategy: 2 Blue Chip Dividends Now Way Too Cheap",
      "id": 134113257,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1126636461/image_1126636461.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Verizonâs 5G growth and Bristol Myers Squibbâs innovation both provide strong income and growth prospects. Read more on BMY and VZ stocks here.",
      "url": "https://finnhub.io/api/news?id=8cb1e0015ec3a9a8b6510f0e1cdc81716bfea4a25991c7feab7e8c1c59938fa5"
    }
  }
]